Anebulo Pharmaceuticals Aktie
WKN DE: A3CM1D / ISIN: US0345691036
|
30.09.2025 01:25:54
|
Anebulo Pharmaceuticals, Inc. Loss At -$2.14 Mln In Q4
(RTTNews) - Anebulo Pharmaceuticals, Inc. (ANEB) reported Loss for fourth quarter of -$2.14 million
The company's earnings came in at -$2.14 million, or -$0.05 per share. This compares with -$1.35 million, or -$0.05 per share, last year.
Anebulo Pharmaceuticals, Inc. earnings at a glance (GAAP) :
-Earnings: -$2.14 Mln. vs. -$1.35 Mln. last year. -EPS: -$0.05 vs. -$0.05 last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Anebulo Pharmaceuticals Inc Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Anebulo Pharmaceuticals Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
| Anebulo Pharmaceuticals Inc Registered Shs | 2,67 | -0,37% |
|